Donatella Raspadori

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

Monica Bocchia, S Gentili, Elisabetta Abruzzese et al. · The Lancet · 2005 · 230 citations · Full text

Vaccination, Hematological Malignancy, Chronic Myeloid Leukaemia +11

CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis

Donatella Raspadori, Daniela Damiani, M. Lenoci et al. · Leukemia · 2001 · 170 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors

Davide Rossi, Elisa Sozzi, Alessia Puma et al. · British Journal of Haematology · 2009 · 148 citations

Lymphocyte Development, Cmbl Management, Immunodeficiencies +26

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate

F. Lauria, Donatella Raspadori, Damiano Rondelli et al. · Leukemia · 1997 · 143 citations

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Cd34 Positivity +11

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

Monica Bocchia, S Gentili, Elisabetta Abruzzese et al. · The Lancet · 2005 · 135 citations

Vaccination, Hematological Malignancy, Chronic Myeloid Leukaemia +11